Compare Moderna, Inc. (MRNA) vs Tractor Supply Co (TSCO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Tractor Supply Co — how do they compare? Moderna, Inc. trades at $225.15 (market cap $78.65B), while Tractor Supply Co trades at $33.65 (market cap $17.44B). The key difference: Moderna, Inc. is far larger — about 4.5× Tractor Supply Co's market cap, and Tractor Supply Co pays a 2.87% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Moderna, Inc. for 59 Days and Tractor Supply Co for 89 Days on average.
| MRNA | TSCO | |
|---|---|---|
Market Cap | $78.65B | $17.44B |
Volume | 37,373,437 | 10,598,723 |
Sector | Health | Consumer Cyclical |
52-Week High | $203.46 | $56.37 |
52-Week Low | $22.36 | $29.14 |
Typical Hold Time | 59 Days | 89 Days |
Enterprise Value | $74.80B | $23.76B |
Dividend Yield | — | 2.87% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Moderna (MRNA) trades at $225.00, up 14.52% in 24 hours, approaching its 52-week high. The stock shows strong technical momentum with bullish moving averages and support at $194. Fundamentally, while revenue has declined from pandemic peaks to $1.92B in 2025, the company continues to beat EPS expectations and maintains a robust pipeline in oncology and respiratory vaccines. Recent inclusion in the Nasdaq-100 index has generated positive momentum, though valuation metrics remain elevated with a P/S ratio of 35.08.
Outlook remains bifurcated - significant growth potential exists in the cancer vaccine pipeline and respiratory vaccine expansion, but current valuations appear stretched relative to financial performance. Key risks include execution challenges in new therapeutic areas, competitive pressure from Pfizer/BioNTech, and dependence on pipeline success beyond COVID-19 vaccines. Analyst consensus shows cautious optimism with a $115.70 price target despite recent downgrades.
Tractor Supply (TSCO) trades at $33.64, up 3.43% today, with a bullish technical signal from moving averages but mixed oscillators. Revenue grew to $15.52B in 2025, though net income margin has declined to 6.42%. Recent earnings have missed expectations, and cash flow trends show variability. The company maintains a strong dividend streak and continues community investments, as highlighted in recent news.
The outlook is mixed: analyst consensus is a Buy with a $36.76 target, but consecutive earnings misses and margin pressure pose risks. Upside hinges on execution amid cyclical challenges, while institutional selling and competitive threats warrant caution for investors seeking stability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Tractor Supply Co
Tractor Supply is the largest operator of retail farm and ranch stores in the United States. The company targets recreational farmers and ranchers and has little exposure to commercial and industrial farm operations. Currently, the company operates 2,016 of its namesake banners in 49 states and 178 Petsense stores. Stores are typically located in towns outside of urban areas and in rural communities. In fiscal 2021, revenue consisted primarily of livestock and pet (47%), hardware, tools, and truck (21%), and seasonal gift and toy (21%).
Read more on TSCO →
